Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of remifentanil on cardiac function in patients with diastolic dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)

Snippet

Sponsor: Yeditepe University | Conditions: Diastolic Dysfunction | Phase 4 | Status: UNKNOWN